Search research articles
Contact Us
Filters
Showing results (71-80 of 115) with videos related to
Page
of 12
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
October 2, 2022
Predictive Biomarkers for Immunotherapy in Lung Cancer: Perspective From the International Association for the Study of Lung Cancer Pathology Committee
Mari Mino-Kenudson, Kurt Schalper, Wendy Cooper, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
December 2, 2014
Lungscape: resected non-small-cell lung cancer outcome by clinical and pathological parameters
Solange Peters, Walter Weder, Urania Dafni, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
November 22, 2021
The 2021 WHO Classification of Lung Tumors: Impact of Advances Since 2015
Andrew G Nicholson, Ming S Tsao, Mary Beth Beasley, et al.
Lung Cancer (Amsterdam, Netherlands)
|
December 6, 2011
The challenge of NSCLC diagnosis and predictive analysis on small samples. Practical approach of a working group
Erik Thunnissen, Keith M Kerr, Felix J F Herth, et al.
Archives of Pathology & Laboratory Medicine
|
January 19, 2016
Programmed Death Ligand-1 Immunohistochemistry--A New Challenge for Pathologists: A Perspective From Members of the Pulmonary Pathology Society
Lynette M Sholl, Dara L Aisner, Timothy Craig Allen, et al.
Archives of Pathology & Laboratory Medicine
|
May 20, 2016
Liquid Biopsy in Lung Cancer: A Perspective From Members of the Pulmonary Pathology Society
Lynette M Sholl, Dara L Aisner, Timothy Craig Allen, et al.
Journal of Clinical Pathology
|
October 21, 2011
Causes of pulmonary granulomas: a retrospective study of 500 cases from seven countries
Sanjay Mukhopadhyay, Carol F Farver, Laszlo T Vaszar, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
December 4, 2016
PD-L1 Immunohistochemistry Assays for Lung Cancer: Results from Phase 1 of the Blueprint PD-L1 IHC Assay Comparison Project
Fred R Hirsch, Abigail McElhinny, Dave Stanforth, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
August 21, 2015
The 2015 World Health Organization Classification of Lung Tumors: Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification
William D Travis, Elisabeth Brambilla, Andrew G Nicholson, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
November 20, 2019
Programmed death-ligand 1 expression influenced by tissue sample size. Scoring based on tissue microarrays' and cross-validation with resections, in patients with, stage I-III, non-small cell lung carcinoma of the European Thoracic Oncology Platform Lungscape cohort
Erik Thunnissen, Keith M Kerr, Urania Dafni, et al.
Page
of 12
Search research articles
Search
Showing results (71-80 of 115) with videos related to
Sort By:
Page
of 12
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
October 2, 2022
Predictive Biomarkers for Immunotherapy in Lung Cancer: Perspective From the International Association for the Study of Lung Cancer Pathology Committee
Mari Mino-Kenudson, Kurt Schalper, Wendy Cooper, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
December 2, 2014
Lungscape: resected non-small-cell lung cancer outcome by clinical and pathological parameters
Solange Peters, Walter Weder, Urania Dafni, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
November 22, 2021
The 2021 WHO Classification of Lung Tumors: Impact of Advances Since 2015
Andrew G Nicholson, Ming S Tsao, Mary Beth Beasley, et al.
Lung Cancer (Amsterdam, Netherlands)
|
December 6, 2011
The challenge of NSCLC diagnosis and predictive analysis on small samples. Practical approach of a working group
Erik Thunnissen, Keith M Kerr, Felix J F Herth, et al.
Archives of Pathology & Laboratory Medicine
|
January 19, 2016
Programmed Death Ligand-1 Immunohistochemistry--A New Challenge for Pathologists: A Perspective From Members of the Pulmonary Pathology Society
Lynette M Sholl, Dara L Aisner, Timothy Craig Allen, et al.
Archives of Pathology & Laboratory Medicine
|
May 20, 2016
Liquid Biopsy in Lung Cancer: A Perspective From Members of the Pulmonary Pathology Society
Lynette M Sholl, Dara L Aisner, Timothy Craig Allen, et al.
Journal of Clinical Pathology
|
October 21, 2011
Causes of pulmonary granulomas: a retrospective study of 500 cases from seven countries
Sanjay Mukhopadhyay, Carol F Farver, Laszlo T Vaszar, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
December 4, 2016
PD-L1 Immunohistochemistry Assays for Lung Cancer: Results from Phase 1 of the Blueprint PD-L1 IHC Assay Comparison Project
Fred R Hirsch, Abigail McElhinny, Dave Stanforth, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
August 21, 2015
The 2015 World Health Organization Classification of Lung Tumors: Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification
William D Travis, Elisabeth Brambilla, Andrew G Nicholson, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
November 20, 2019
Programmed death-ligand 1 expression influenced by tissue sample size. Scoring based on tissue microarrays' and cross-validation with resections, in patients with, stage I-III, non-small cell lung carcinoma of the European Thoracic Oncology Platform Lungscape cohort
Erik Thunnissen, Keith M Kerr, Urania Dafni, et al.
Page
of 12